467 related articles for article (PubMed ID: 7788996)
1. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy.
Kobayashi H; Kotoura Y; Hosono M; Sakahara H; Hosono M; Yao ZS; Tsuboyama T; Yamamuro T; Endo K; Konishi J
Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996
[TBL] [Abstract][Full Text] [Related]
2. The role of Thallium-201 scintigraphy and Tc-99m pentavalent dimercaptosuccinic acid in diagnosis and grading of chondrosarcoma.
Jo O; Schlicht S; Slavin J; Di Bella C; Pang G; Powell G; Spelman T; Choong PF
Eur J Radiol; 2020 Apr; 125():108846. PubMed ID: 32062570
[TBL] [Abstract][Full Text] [Related]
3. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
[TBL] [Abstract][Full Text] [Related]
4. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J
J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696
[TBL] [Abstract][Full Text] [Related]
5. Both a visual and a semiquantitative analysis for differentiating benign from malignant chondrogenic bone tumors using Tc-99m (V) DMSA scintigraphy: a prospective study.
Shinya T; Sato S; Kunisada T; Inai R; Yanai H; Ozaki T; Kanazawa S
Nucl Med Commun; 2015 Aug; 36(8):802-7. PubMed ID: 25932541
[TBL] [Abstract][Full Text] [Related]
6. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of bone scintigraphy in differential diagnosis of benign bone tumors].
Okuyama T; Suzuki H; Nakamoto K; Suzuki S
Kaku Igaku; 1982 Dec; 19(10):1519-30. PubMed ID: 6302357
[No Abstract] [Full Text] [Related]
8. Pentavalent technetium-99m-dimercaptosuccinic acid scintigraphy in renal osteodystrophy.
Higuchi T; Hirano T; Inoue T; Aoki J; Ueki K; Wakamatsu R; Yano S; Naruse T; Endo K
J Nucl Med; 1998 Mar; 39(3):541-3. PubMed ID: 9529307
[TBL] [Abstract][Full Text] [Related]
9. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
Ohnishi T; Noguchi S; Murakami N; Tajiri J; Morita M; Tamaru M; Hoshi H; Watanabe K
J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
[TBL] [Abstract][Full Text] [Related]
10. Soft-tissue tumors: diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy.
Kobayashi H; Sakahara H; Hosono M; Shirato M; Endo K; Kotoura Y; Yamamuro T; Konishi J
Radiology; 1994 Jan; 190(1):277-80. PubMed ID: 8259419
[TBL] [Abstract][Full Text] [Related]
11. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy.
Yüksel D; Ilgan S; Arslan N; Uğur O; Oztürk E; Bayhan H
Clin Nucl Med; 2000 Mar; 25(3):193-6. PubMed ID: 10698416
[TBL] [Abstract][Full Text] [Related]
12. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs.
Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
Eur J Nucl Med; 1992; 19(10):890-3. PubMed ID: 1333404
[TBL] [Abstract][Full Text] [Related]
13. Bone metastases demonstrated by pentavalent Tc-99m DMSA and Tc-99m HMDP.
Hirano T; Otake H
Clin Nucl Med; 1997 Sep; 22(9):640-1. PubMed ID: 9298304
[No Abstract] [Full Text] [Related]
14. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
Yen TC; King KL; Yang AH; Liu RS; Yeh SH
J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.
Lam AS; Puncher MR; Blower PJ
Eur J Nucl Med; 1996 Dec; 23(12):1575-82. PubMed ID: 8929310
[TBL] [Abstract][Full Text] [Related]
16. Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas.
Hendel HW; Daugaard S; Kjaer A
Clin Nucl Med; 2002 Sep; 27(9):622-4. PubMed ID: 12192277
[TBL] [Abstract][Full Text] [Related]
17. Imaging of head and neck tumors with technetium(V)-99m DMSA. A new tumor-seeking agent.
Ohta H; Endo K; Fujita T; Nakashima T; Sakahara H; Torizuka K; Shimizu Y; Ishii Y; Makimoto K; Hata N
Clin Nucl Med; 1985 Dec; 10(12):855-60. PubMed ID: 3000682
[TBL] [Abstract][Full Text] [Related]
18. Poor renal uptake of Tc-99m DMSA and Tc-99m MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate.
Kim SE; Cho JT; Lee DS; Chung JK; Kim S; Lee MC; Lee JS; Koh CS
Clin Nucl Med; 1995 Mar; 20(3):215-9. PubMed ID: 7750213
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions.
Sahin M; Basoglu T; Bernay I; Yapici O; Canbaz F; Yalin T
Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327
[TBL] [Abstract][Full Text] [Related]
20. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
